Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactate Normalization in Septic Shock Fluid Therapy
NCT05629780Completed
- Sponsor
- Karolinska University Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Randomised, open-label trial in septic shock (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Time to resolution of hyperlactatemia (< 2mmol/L) at 72 hours. Started Sep 2022; status: completed.
02
Conditions
septic shock
Beyond the preview
Go deeper on NCT05629780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05629780.